SEC Form 4Coverage since Aug 8, 2025Open-market trades only
$NTRA insider trading
Over the last 12 months, Natera insiders reported no purchases and 154 sales totaling $327.9M across SEC Form 4 filings. 93% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $327.9M 154 events
- Events · 12m
- 154 Form 4 filings, grouped
- Insiders · 12m
- 12 distinct reporters
- 10b5-1 share
- 93% of events, not dollars
Side
Price · $NTRA · 3Mvia TradingView
Top insiders · 12m
Sheena Jonathan—32× · $21.2M
Chapman Steven LeonardCEO AND PRESIDENT30× · $94.3M
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS24× · $17.5M
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER15× · $23.8M
Rabinowitz MatthewEXECUTIVE CHAIRMAN13× · $82.7M
All insider trades
50 of 159 events
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER · O | ▼ Sale | 6,517 | $321.53 | $2.1M | -3.2% | plan · late |
| Aug 10, 2026 | Sheena JonathanD | ▼ Sale | 6,000 | $325.32 | $2.0M | -2.5% | plan · late |
| Aug 7, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN · O·D | ▼ Sale | 2,000 | $320.9 | $642K | -50% | plan · indirect |
| Aug 7, 2026 | Sheena JonathanD | ▼ Sale | 9,150 | $315.66 | $2.9M | -3.7% | plan · 10 tranches |
| Aug 4, 2026 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER · O | ▼ Sale | 795 | $271.74 | $216K | -1.5% | plan · 2 tranches |
| Aug 3, 2026 | Chapman Steven LeonardCEO AND PRESIDENT · O·D | ▼ Sale | 3,076 | $266.39 | $819K | -3% | plan · 7 tranches |
| Aug 3, 2026 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER · O | ▼ Sale | 295 | $267.99 | $79K | -0.2% | plan |
| Aug 3, 2026 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS · O | ▼ Sale | 3,410 | $265.58 | $906K | -2.6% | plan · 7 tranches |
| Aug 3, 2026 | RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER · O | ▼ Sale | 334 | $267.99 | $90K | -0.2% | plan |
| Aug 3, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN · O·D | ▼ Sale | 731 | $267.99 | $196K | — | plan |
| Aug 3, 2026 | Sheena JonathanD | ▼ Sale | 109 | $267.99 | $29K | — | plan |
| Jul 29, 2026 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER · O | ▼ Sale | 5,064 | $253.28 | $1.3M | -8.8% | plan · 5 tranches |
| Jul 28, 2026 | Sheena JonathanD | ▼ Sale | 479 | $257.93 | $124K | -0.2% | plan · 2 tranches |
| Jul 28, 2026 | RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER · O | ▼ Sale | 1,887 | $257.08 | $485K | -1.1% | plan · 2 tranches |
| Jul 28, 2026 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS · O | ▼ Sale | 2,214 | $257 | $569K | -1.6% | plan · 2 tranches |
| Jul 28, 2026 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER · O | ▼ Sale | 1,713 | $257 | $440K | -0.9% | plan · 2 tranches |
| Jul 28, 2026 | Chapman Steven LeonardCEO AND PRESIDENT · O·D | ▼ Sale | 5,770 | $256.51 | $1.5M | -5.3% | plan · 2 tranches |
| Jul 27, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN · O·D | ▼ Sale | 1,718 | $260.49 | $448K | -0.1% | plan |
| Jul 15, 2026 | Sheena JonathanD | ▼ Sale | 1,500 | $273.88 | $411K | -7.7% | plan · 8 tranches · indirect |
| Jul 15, 2026 | Chapman Rowan ED | ▼ Sale | 135 | $274.82 | $37K | -2.8% | plan |
| Jul 13, 2026 | Sheena JonathanD | ▼ Sale | 3,150 | $265.68 | $837K | -1.3% | plan · 6 tranches |
| Jul 6, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN · O·D | ▼ Sale | 1,000 | $280 | $280K | -20% | plan · indirect |
| Jul 1, 2026 | RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER · O | ▼ Sale | 16,800 | $272.29 | $4.6M | -8.9% | plan · 12 tranches |
| Jul 1, 2026 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS · O | ▼ Sale | 3,000 | $272.9 | $819K | -2.2% | plan · 3 tranches |
| Jun 24, 2026 | RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER · O | ▼ Sale | 33,600 | $251.65 | $8.5M | -15.1% | plan · 4 tranches |
| Jun 24, 2026 | ROSENMAN HERMD | ▼ Sale | 16,530 | $250 | $4.1M | -79.5% | plan |
| Jun 17, 2026 | Sheena JonathanD | ▼ Sale | 1,500 | $219.87 | $330K | -7.4% | plan · 9 tranches · indirect |
| Jun 16, 2026 | Chapman Rowan ED | ▼ Sale | 2,964 | $216.78 | $643K | -48.7% | plan |
| Jun 15, 2026 | Sheena JonathanD | ▼ Sale | 3,150 | $211.14 | $665K | -1.2% | plan · 4 tranches |
| Jun 15, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN · O·D | ▼ Sale | 100,000 | $214.47 | $21.4M | -4.2% | plan · 21 tranches |
| Jun 5, 2026 | Marcus Gail BoxerD | ▼ Sale | 11,000 | $217.21 | $2.4M | -64% | 4 tranches |
| Jun 4, 2026 | Chapman Steven LeonardCEO AND PRESIDENT · O·D | ▼ Sale | 3,409 | $226.97 | $774K | -3% | plan |
| Jun 4, 2026 | Chapman Steven LeonardCEO AND PRESIDENT · O·D | ▼ Sale | 6,751 | $226.15 | $1.5M | -5.7% | plan |
| Jun 4, 2026 | Chapman Steven LeonardCEO AND PRESIDENT · O·D | ▼ Sale | 1,630 | $224.99 | $367K | -1.4% | plan |
| Jun 4, 2026 | Chapman Steven LeonardCEO AND PRESIDENT · O·D | ▼ Sale | 1,443 | $223.91 | $323K | -1.2% | plan |
| Jun 4, 2026 | Chapman Steven LeonardCEO AND PRESIDENT · O·D | ▼ Sale | 6,500 | $223.34 | $1.5M | -5.1% | plan |
| Jun 4, 2026 | Chapman Steven LeonardCEO AND PRESIDENT · O·D | ▼ Sale | 2,006 | $222.25 | $446K | -1.5% | plan |
| Jun 4, 2026 | Chapman Steven LeonardCEO AND PRESIDENT · O·D | ▼ Sale | 2,400 | $220.19 | $528K | -1.8% | plan |
| Jun 4, 2026 | Chapman Steven LeonardCEO AND PRESIDENT · O·D | ▼ Sale | 2,758 | $219.08 | $604K | -2% | plan |
| Jun 4, 2026 | Chapman Steven LeonardCEO AND PRESIDENT · O·D | ▼ Sale | 1,742 | $218.28 | $380K | -1.3% | plan |
| Jun 4, 2026 | Chapman Steven LeonardCEO AND PRESIDENT · O·D | ▼ Sale | 2,351 | $217.04 | $510K | -1.7% | plan |
| Jun 4, 2026 | Chapman Steven LeonardCEO AND PRESIDENT · O·D | ▼ Sale | 5,499 | $216.13 | $1.2M | -3.8% | plan |
| Jun 4, 2026 | Chapman Steven LeonardCEO AND PRESIDENT · O·D | ▼ Sale | 1,300 | $214.83 | $279K | -0.9% | plan |
| Jun 4, 2026 | Chapman Steven LeonardCEO AND PRESIDENT · O·D | ▼ Sale | 2,503 | $213.44 | $534K | -1.7% | plan |
| Jun 4, 2026 | Chapman Steven LeonardCEO AND PRESIDENT · O·D | ▼ Sale | 832 | $212.42 | $177K | -0.6% | plan |
| Jun 1, 2026 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS · O | ▼ Sale | 572 | $220.67 | $126K | -0.4% | plan |
| Jun 1, 2026 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS · O | ▼ Sale | 213 | $219.34 | $47K | -0.2% | plan |
| Jun 1, 2026 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS · O | ▼ Sale | 413 | $218.84 | $90K | -0.3% | plan |
| Jun 1, 2026 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS · O | ▼ Sale | 1,802 | $217.52 | $392K | -1.3% | plan |
| Jun 1, 2026 | BOTHA ROELOFD | ▼ Sale | 2,450 | $223.83 | $548K | -0.2% | indirect |
Every $NTRA filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Natera filings can reach your inbox instead.
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $NTRA feed.